Oncology
ASCO 2023 – Dr Lalan Wilfong

ASCO 2023 – Dr Lalan Wilfong

In the last video from ASCO 2023, we step away from the R&D side to talk about drug costs and payment models.

Oncology
ASCO 2023 Jaydev Thakkar

ASCO 2023 – Jaydev Thakkar

In our penultimate video from ASCO 2023, editor-in-chief Jonah Comstock touches base with Biofourmis chief operating officer Jaydev Thakkar.

Oncology
ASCO 2023 Mark Reisenauer

ASCO 2023 – Mark Reisenauer

As we approach the last of our exclusive coverage of ASCO 2023, editor-in-chief Jonah Comstock speaks with Mark Reisenauer, president of US commercial at Astellas.

Sales & Marketing

Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Digital

Market Access

Editor's Picks

  1. GBL joins CVC in €10.7bn takeover bid for Recordati
  2. After refusing to resign, CDER head Høeg is fired
  3. As Ebola deaths climb, search begins for vaccine
  4. NICE changes stance on Genmab's cervical cancer drug
  5. Remepy's hybrid Parkinson's therapy poised for phase 3

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more